A growing focus on precision healthcare is strengthening the global demand for cancer biomarkers, particularly as cancer prevalence continues to rise and diagnostic technologies advance. The global cancer biomarkers market is supported by technological progress and the increasing adoption of personalized medicine, with opportunities emerging across North America, Europe, Asia Pacific,...